Neocitrullamon

Neocitrullamon
Clinical data
ATC code	N03AB03 (WHO) ;
Identifiers
	IUPAC name 2-Amino-5-(2,5-dioxo-4,4-diphenylimidazolidin-1-yl)pentanoic acid;
CAS Number	38964-88-4;
PubChem CID	3084726;
ChemSpider	2341748;
UNII	7L5LMT7B2H;
ChEBI	CHEBI:134734;
ChEMBL	ChEMBL3707389;
CompTox Dashboard (EPA)	DTXSID50959812 ;
ECHA InfoCard	100.049.276
Chemical and physical data
Formula	C20H21N3O4
Molar mass	367.405 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES C1=CC=C(C=C1)C2(C(=O)N(C(=O)N2)CCCC(C(=O)O)N)C3=CC=CC=C3;
	InChI InChI=1S/C20H21N3O4/c21-16(17(24)25)12-7-13-23-18(26)20(22-19(23)27,14-8-3-1-4-9-14)15-10-5-2-6-11-15/h1-6,8-11,16H,7,12-13,21H2,(H,22,27)(H,24,25); Key:PAJBBDCZSMDSFL-UHFFFAOYSA-N;

Neocitrullamon, also known as amino(diphenylhydantoin) valeric acid is an anticonvulsant.[1][2]

References

"ATC N03AB03". whocc.no. Retrieved 31 August 2018.
"[Citrullamon and Neo-Citrullamon]". Medizinische Klinik (in German). 53 (3): 117–8. January 1958. PMID 13516346.

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.